Constantiam Biosciences
PrivateLast Round
Seed
Jun 18, 2026
Est. Valuation
$0
Total Funding Raised
$23.95M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Constantiam Biosciences is a biotechnology company that develops precision medicine therapies and functional genomics platforms to decode human genetic variation for the treatment of severe genetic disorders.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Drug Discovery, Biotechnology, Healthcare Analytics, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Constantiam Biosciences Comparables
Compare Constantiam Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Heligenics, Inc. | 86% | |
| Ranomics | 82% | |
| Atlas Biotech | 80% | |
Constantiam Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 18, 2026 | ||||
| Grant | Sep 4, 2024 | ||||
| Series A | Oct 19, 2023 | ||||
| Grant | Feb 1, 2023 | ||||
| Grant | Aug 15, 2022 | ||||
Grant | Mar 1, 2021 |
Constantiam Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| OrbiMed | Series A |
| National Institute on Aging | Grant |
| Atlas Venture | Series A |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Completed a Seed funding round.
- Sep 4, 2024
Secured $2M from National Human Genome Research Institute and others.
Constantiam Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Constantiam Biosciences's valuation, stock price, and market status.